HIGH

Hydromorphone HCL PF, 10mg/50 mL (0.2mg/mL) in NACL, Injection for IV use, 50 mL Syringe, STAQ Pharma Inc., 14135 E 42nd Ave, Denver, Colorado, NDC 73177-0104-05.

Labeling: Incorrect or Missing Lot and/or Exp Date

Quick Facts at a Glance

Recall Date
October 9, 2025
Hazard Level
HIGH
Brand
STAQ Pharma
Geographic Scope
1 states

Hazard Information

Labeling: Incorrect or Missing Lot and/or Exp Date

What You Should Do

Consumers and healthcare providers should stop using this product immediately. Contact STAQ Pharma, Inc. or your healthcare provider for guidance. Notification method: Letter

Full Description

Hydromorphone HCL PF, 10mg/50 mL (0.2mg/mL) in NACL, Injection for IV use, 50 mL Syringe, STAQ Pharma Inc., 14135 E 42nd Ave, Denver, Colorado, NDC 73177-0104-05.. Reason: Labeling: Incorrect or Missing Lot and/or Exp Date. Classification: Class III. Distribution: Nationwide in the U.S.

View Original Recall on FDA - Drug Safety

Want Alerts Like This?

Get notified about recalls in categories you care about.

Product Classification

Product Details

Model Numbers
Lot #: 25104595A
Expiry: 27DEC2025.
Affected States
ALL
Report Date
October 22, 2025
Source Agency
FDA - Drug Safety
Recall Status
ACTIVE

Related Recalls

HIGH

Sucralfate Tablets, USP 1 gram, 100 Tablets, (10x10), Rx Only, Distributed by: American Health Packaging, Columbus, Ohio 43217, NDC 60687-695-01 - Carton NDC [60687-695-11- Unit Dose]

CGMP Deviations: The recalling firm filed for Chapter 11 on September 30, 2024. As a result, it cannot monitor the quality program and hence cannot assure that products meet the identity, strength, quality, and purity characteristics that they are purported or represented to possess, rendering the products adulterated.

SUCRALFATE
CGMP Deviations:
Read more